NRS 585.450
Misbranded drugs and devices: Directions for use and warnings on label.

1.

A drug or device shall be deemed to be misbranded unless its label bears:

(a)

Adequate directions for use; and

(b)

Such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration or administration or application, in such manner and form as are necessary for the protection of users.

2.

Where any requirement of paragraph (a) of subsection 1, as applied to any drug or device, is not necessary for the protection of the public health, the Commissioner shall promulgate regulations exempting such drug or device from such requirements.

Source: Section 585.450 — Misbranded drugs and devices: Directions for use and warnings on label., https://www.leg.state.nv.us/NRS/NRS-585.html#NRS585Sec450.

585.370
Adulterated drugs and devices: Poisonous or insanitary ingredients. 585.380
Adulterated drugs and devices: Strength, quality or purity differing from official compendium. 585.390
Adulterated drugs and devices: Misrepresentation of strength, quality or purity if drug not in compendium. 585.400
Adulterated drugs and devices: Mixture with or substitution of another substance. 585.410
Misbranded drugs and devices: False or misleading label. 585.420
Misbranded drugs and devices: Contents of label on package. 585.430
Misbranded drugs and devices: Habit-forming substances. 585.440
Misbranded drugs and devices: Designation of drug by name not in compendium. 585.450
Misbranded drugs and devices: Directions for use and warnings on label. 585.460
Misbranded drugs and devices: Misleading container 585.470
Misbranded drugs and devices: Health-endangering when used as prescribed. 585.480
Misbranded drugs and devices: Drug containing amidopyrine, barbituric acid, cinchophen, dinitrophenol or sulfanilamide sold without prescription. 585.485
Restrictions on sale of dimethyl sulfoxide 585.490
Introduction or delivery for introduction of new drug into intrastate commerce before application is effective prohibited. 585.495
Licensing of manufacture of amygdalin and procaine hydrochloride 585.497
Assessment on gross receipts from sale of amygdalin and procaine hydrochloride.

Last Updated

Feb. 5, 2021

§ 585.450’s source at nv.us

Stay Connected

Join thousands of people who receive monthly site updates.

Get Legal Help

The State Bar of Nevada runs a service for finding an attorney in good standing. Initial consultations are usually free or discounted: Lawyer Referral Service

Committed to Public Service

We will always provide free access to the current law. In addition, we provide special support for non-profit, educational, and government users. Through social entrepreneurship, we’re lowering the cost of legal services and increasing citizen access.

Navigate

California:	Codes
Colorado:	C.R.S.
Nevada:	NRS
New York:	Laws
Oregon:	OAR, ORS
Texas:	Statutes
World:	Rome Statute, International Dictionary

Location: https://nevada.public.law/statutes/nrs_585.450

Original Source: Section 585.450 — Misbranded drugs and devices: Directions for use and warnings on label., https://www.leg.state.nv.us/NRS/NRS-585.html#NRS585Sec450 (last accessed Feb. 5, 2021).